Overall, the U.S. medical marijuana clinical study can be described as modest, fragmented, occurring without major industry leaders but growing and with more activity than ever before. 2017 set a new record as 34 study starts listed marijuana as the “intervention”. There was a slight drop off in 201
Read more by clicking here.
Lucas Bols has entered a joint venture with Edrington under the name Maxxium BeLux for distribution in Belgium and Luxembourg. Source